Patents by Inventor Laetitia Cohen-Tannoudji

Laetitia Cohen-Tannoudji has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CONCENTRATED HUMAN IMMUNOGLOBULIN COMPOSITION
    Publication number: 20160030563
    Abstract: A liquid pharmaceutical composition containing human immunoglobulin G, preferably at 230 g/l or higher. The composition, suitable for subcutaneous or intramuscular administration, can be used to treat various diseases, e.g., an antibody production defect and Kawasaki disease.
    Type: Application
    Filed: October 9, 2015
    Publication date: February 4, 2016
    Inventors: Sylvain Huille, Laetitia Cohen-Tannoudji, Florence Arvis, Alexandra Paillard
  • Concentrated human immunoglobulin composition
    Patent number: 9186401
    Abstract: The invention relates to a human immunoglobulin G composition characterized in that the human immunoglobulin G concentration is at least 230 g/l, which is of use in particular for subcutaneous administration.
    Type: Grant
    Filed: July 18, 2011
    Date of Patent: November 17, 2015
    Assignee: Laboratoire Francais Du Fractionnement Et Des Biotechnologies
    Inventors: Sylvain Huille, Laetitia Cohen-Tannoudji, Florence Arvis, Alexandra Paillard
  • STABILIZED HUMAN IMMUNOGLOBULIN COMPOSITION
    Publication number: 20130216522
    Abstract: The invention relates to a liquid pharmaceutical composition comprising human immunoglobulins G (IgGs), comprising at least 200 mM, preferably 250 mM±50 mM, of glycine and between 20 and 100 mg/l of a non-ionic detergent, and having a pH of less than or equal to 4.8.
    Type: Application
    Filed: June 15, 2011
    Publication date: August 22, 2013
    Applicant: Laboratoire Francais Du Fractionnement Et Des Biotechnologies
    Inventors: Sylvain Huille, Laetitia Cohen-Tannoudji
  • CONCENTRATED HUMAN IMMUNOGLOBULIN COMPOSITION
    Publication number: 20130121991
    Abstract: The invention relates to a human immunoglobulin G composition characterized in that the human immunoglobulin G concentration is at least 230 g/l, which is of use in particular for subcutaneous administration.
    Type: Application
    Filed: July 18, 2011
    Publication date: May 16, 2013
    Applicant: Laboratoire Francais Du Fractionnement Et Des Biotechnologies
    Inventors: Sylvain Huille, Laetitia Cohen-Tannoudji, Florence Arvis, Alexandra Paillard